The GBM Trial Paradox: 1,913 Trials, Zero Breakthrough Approvals
GBM clinical trial analysis: 1,913 trials, yet zero breakthrough approvals. Three insights explain the gap and where glioblastoma research must go next.
2 min read
Topic
Immunotherapy
1 K-Dense article on Immunotherapy — research automation, benchmarks, and case studies from the K-Dense team.